» Articles » PMID: 35873025

Long Non-coding RNA (lncRNA): A Potential Therapeutic Target in Acute Lung Injury

Overview
Journal Genes Dis
Date 2022 Jul 25
PMID 35873025
Authors
Affiliations
Soon will be listed here.
Abstract

Acute Lung Injury (ALI) and its severe form Acute Respiratory Distress Syndrome (ARDS) are the major cause of ICU death worldwide. ALI/ARDS is characterized by severe hypoxemia and inflammation that leads to poor lung compliance. Despite many advances in understanding and management, ALI/ARDS is still causing significant morbidity and mortality. Long non-coding RNA (lncRNA) is a fast-growing topic in lung inflammation and injury. lncRNA is a class of non-coding RNA having a length of more than 200 nucleotides. It has been a center of research for understanding the pathophysiology of various diseases in the past few years. Multiple studies have shown that lncRNAs are abundant in acute lung injury/injuries in mouse models and cell lines. By targeting these long non-coding RNAs, many investigators have demonstrated the alleviation of ALI in various mouse models. Therefore, lncRNAs show great promise as a therapeutic target in ALI. This review provides the current state of knowledge about the relationship between lncRNAs in various biological processes in acute lung injury and its use as a potential therapeutic target.

Citing Articles

Vitexin mitigates oxidative stress, mitochondrial damage, pyroptosis and regulates small nucleolar RNA host gene 1/DNA methyltransferase 1/microRNA-495 axis in sepsis-associated acute lung injury.

Zaki A, Mohsin M, Khan S, Khan A, Ahmad S, Verma A Inflammopharmacology. 2024; .

PMID: 39641834 DOI: 10.1007/s10787-024-01609-6.


Advancements in long non-coding RNA-based therapies for cancer: targeting, delivery, and clinical implications.

Ammad M, Javed Z, Sadia H, Ahmed R, Akbar A, Nadeem T Med Oncol. 2024; 41(11):292.

PMID: 39428417 DOI: 10.1007/s12032-024-02534-y.


Epigenetic regulatory mechanism of macrophage polarization in diabetic wound healing (Review).

Song J, Wu Y, Chen Y, Sun X, Zhang Z Mol Med Rep. 2024; 31(1).

PMID: 39422035 PMC: 11551531. DOI: 10.3892/mmr.2024.13367.


Natural products: A potential immunomodulators against inflammatory-related diseases.

Priya T, Ramalingam V, Babu K Inflammopharmacology. 2024; 32(5):2821-2859.

PMID: 39196458 DOI: 10.1007/s10787-024-01562-4.


Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.

Zhou M, Meng L, He Q, Ren C, Li C Front Pharmacol. 2024; 15:1321095.

PMID: 38288441 PMC: 10822936. DOI: 10.3389/fphar.2024.1321095.


References
1.
Peng W, Koirala P, Mo Y . LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017; 36(41):5661-5667. PMC: 6450570. DOI: 10.1038/onc.2017.184. View

2.
Mohsin M, Tabassum G, Ahmad S, Ali S, Syed M . The role of mitophagy in pulmonary sepsis. Mitochondrion. 2021; 59:63-75. DOI: 10.1016/j.mito.2021.04.009. View

3.
Zhou Z, Zhu Y, Gao G, Zhang Y . Long noncoding RNA SNHG16 targets miR-146a-5p/CCL5 to regulate LPS-induced WI-38 cell apoptosis and inflammation in acute pneumonia. Life Sci. 2019; 228:189-197. DOI: 10.1016/j.lfs.2019.05.008. View

4.
Li X, Zhuang X, Qiao T . Role of ferroptosis in the process of acute radiation-induced lung injury in mice. Biochem Biophys Res Commun. 2019; 519(2):240-245. DOI: 10.1016/j.bbrc.2019.08.165. View

5.
Lin L, Niu G, Zhang X . Influence of lncRNA MALAT1 on septic lung injury in mice through p38 MAPK/p65 NF-κB pathway. Eur Rev Med Pharmacol Sci. 2019; 23(3):1296-1304. DOI: 10.26355/eurrev_201902_17025. View